To determine whether AML1 mutants play a role in disease progression of CML, we adopted and modified a culture system to assay the ability of a given gene to collaborate with BCR-ABL to induce cell proliferation [34], [41]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.